-
Interpreting In Vitro Cancer Drug Responses
2026-09-11
Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell death are related but non-equivalent components of an in vitro drug response. Its practical contribution is a time-aware framework for designing and interpreting cancer drug assays without treating a single viability endpoint as a complete mechanistic readout.
-
Diminazene Aceturate: Mechanism and Research Use
2026-09-11
Diminazene Aceturate is a research-use di-amidine with trypanocidal activity and the chemical name 4,4-(1-Triazene–1,3–diyl)bis(benzenecarboximidamide). In a mouse sepsis model, the compound was used as a pharmacological ACE2 activator associated with MasR-Sirt1-mediated mitochondrial biogenesis, but this finding does not establish a clinical indication.
-
CFTRinh-172: Applied CFTR Inhibition Workflows
2026-09-10
CFTRinh-172 provides rapid, selective functional blockade for epithelial chloride transport assays, secretory disease models, and trafficking studies. This guide connects practical dosing and readout choices with new evidence showing why CFTR surface abundance and channel activity should be measured separately across cell models.
-
Pcbp1, Mitochondrial Integrity, and B Cell Immunity
2026-09-10
The reference study identifies the RNA-binding protein Pcbp1 as a posttranscriptional regulator of mitochondrial integrity in B cells. By linking Pcbp1 control of Fdxr messenger RNA to complex I function, protein translation, IgM production, and germinal center responses, the work provides a mechanistic framework for understanding how mitochondrial quality supports humoral immunity.
-
Angiotensin 1/2 (5-7) Assay Workflow Guide
2026-09-09
Use Angiotensin 1/2 (5-7) as a defined renin-angiotensin fragment for cardiovascular signaling experiments and receptor-binding studies. Its compact H2N-Ile-His-Pro-OH sequence also enables focused comparisons of peptide length, receptor context, and SARS-CoV-2 spike–receptor interactions.
-
AM 281: A Mechanistic CB1 Research Guide
2026-09-09
AM 281 is a selective CB1 cannabinoid receptor antagonist for dissecting receptor control of astrocytic GLT-1, excitotoxicity, and cognition. This guide translates recent TBI findings into practical assay decisions while distinguishing receptor-level evidence from broader memory impairment research.
-
Dietary Arachidonic Acid and Humoral Immunity
2026-09-08
The reference study shows that dietary arachidonic acid can accelerate and strengthen vaccine-induced neutralizing antibody responses in mice and human volunteers. Its mechanistic contribution is the identification of a lymph-node ARA–PGI2–cAMP–PKA pathway that enhances CD86 expression and AID activity, linking dietary lipid metabolism to germinal-center B-cell function.
-
Olsalazine Sodium: Applied Research Workflows
2026-09-08
Olsalazine Sodium supports complementary workflows in colorectal cancer tumor models, macrophage inflammation assays, and xenobiotic transport research. This guide connects practical formulation and dosing decisions with the reference study’s finding that molecular structure can shape excretion more strongly than transporter-expression changes.
-
S Tag Peptide: Practical Fusion Tag Workflow
2026-09-07
S Tag Peptide (SKU A6007) is a 15-amino acid RNase A-derived peptide used to support recombinant protein solubility improvement and antibody-based detection. It is suitable for S-peptide fusion tag construct design and related protein expression and purification workflows, but it should not be treated as proof of target-protein activity or used in ethanol-based formulations.
-
Maraviroc A8311 for Reproducible CCR5 Assays
2026-09-05
A scenario-driven guide to using Maraviroc (SKU A8311) in CCR5, HIV-1 entry, viability, proliferation, and neuroinflammation workflows. It connects pharmacological benchmarks with practical stock preparation, assay controls, interpretation, and evidence-based product selection.
-
Olsalazine Sodium: Workflows for Cancer & Transport
2026-09-05
Olsalazine Sodium supports two complementary research paths: LTB4-focused inflammation and colorectal cancer models, plus structure-aware xenobiotic clearance assays. This practical guide covers formulation, stepwise assay design, cross-domain interpretation, and troubleshooting for SKU A8490.
-
BMX Kinase and Lysosomal Acidification in Mtb
2026-09-04
A 2026 Nature Communications study identifies a host–pathogen mechanism in which Mycobacterium tuberculosis secretes Chp2 to promote BMX-dependent phosphorylation of ATP6V1E1, impairing V-ATPase assembly and lysosomal acidification. The work links this pathway to bacterial persistence in macrophages and mice, supporting BMX kinase as a potential host-directed tuberculosis target while leaving important translational questions unresolved.
-
Acridine Orange hydrochloride: Practical Guide
2026-09-04
Acridine Orange hydrochloride provides membrane-permeable, differential fluorescence for DNA and RNA assessment in cytochemical and flow-based workflows. It is suitable for cell cycle analysis, apoptosis-oriented screening, and nucleic acid staining, but it should not be treated as a standalone apoptosis proof or as a reagent for long-term solution storage.
-
OSMI-1: O-GlcNAc Transferase Inhibitor Guide
2026-09-03
OSMI-1 is a cell-permeable O-GlcNAc transferase inhibitor that suppresses OGT-dependent protein O-GlcNAcylation. Its reported biochemical potency, cellular viability effect, and zebrafish acute-toxicity benchmarks support use as a mechanistic research tool, not as a validated therapeutic.
-
Superoxide Dismutase Activity Assay Kit Guide
2026-09-03
The Superoxide Dismutase Activity Assay Kit (SKU K2035) provides a colorimetric method for quantifying SOD activity in biological fluids through inhibition of WST-1 formazan formation. It is intended for controlled scientific research, including oxidative stress and enzyme-function studies, and must not be used for diagnostic or medical decisions.